US NRC rules sites can procure radium-223 dichloride for Algeta/Bayer's prostate cancer candidate
14 January 2013
Bayer files prostate cancer drug Alpharadin in the EU
13 December 2012
Algeta and Ablynx collaborate on tumor-targeting Nanobodies
22 November 2012
Algeta prepares for Alpharadin US launch, opening US base
19 September 2012
Four new drugs will change prostate cancer care, says US expert
19 February 2012
Bayer and Algeta’s Alpharadin efficacy confirmed; Almirall to market Xarelto in Spain
13 February 2012
News briefs from breast cancer meeting
12 December 2011
Expanding Norwegian cancer cluster adds new start-ups
31 October 2011
Showing 1-15 of 15 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
